Witt O - Search Results

1

LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.

van Tilburg CM, Kilburn LB, Perreault S, Schmidt R, Azizi AA, Cruz-Martínez O, Zápotocký M, Scheinemann K, Meeteren AYNS, Sehested A, Opocher E, Driever PH, Avula S, Ziegler DS, Capper D, Koch A, Sahm F, Qiu J, Tsao LP, Blackman SC, Manley P, Milde T, Witt R, Jones DTW, Hargrave D, Witt O. van Tilburg CM, et al. Among authors: witt o. BMC Cancer. 2024 Jan 30;24(1):147. doi: 10.1186/s12885-024-11820-x. BMC Cancer. 2024. PMID: 38291372 Free PMC article. Clinical Trial.

2

Valproic acid treatment of glioblastoma multiforme in a child.

Witt O, Schweigerer L, Driever PH, Wolff J, Pekrun A. Witt O, et al. Pediatr Blood Cancer. 2004 Aug;43(2):181. doi: 10.1002/pbc.20083. Pediatr Blood Cancer. 2004. PMID: 15236290 No abstract available.

3

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.

Wegener D, Deubzer HE, Oehme I, Milde T, Hildmann C, Schwienhorst A, Witt O. Wegener D, et al. Among authors: witt o. Anticancer Drugs. 2008 Oct;19(9):849-57. doi: 10.1097/CAD.0b013e32830efbeb. Anticancer Drugs. 2008. PMID: 18765999

4

HDAC family: What are the cancer relevant targets?

Witt O, Deubzer HE, Milde T, Oehme I. Witt O, et al. Cancer Lett. 2009 May 8;277(1):8-21. doi: 10.1016/j.canlet.2008.08.016. Epub 2008 Sep 27. Cancer Lett. 2009. PMID: 18824292 Review.

5

Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.

Milde T, Pfister S, Korshunov A, Deubzer HE, Oehme I, Ernst A, Starzinski-Powitz A, Seitz A, Lichter P, von Deimling A, Witt O. Milde T, et al. Among authors: witt o. Genes Chromosomes Cancer. 2009 Mar;48(3):229-38. doi: 10.1002/gcc.20635. Genes Chromosomes Cancer. 2009. PMID: 19025795

6

Targeting histone deacetylases in neuroblastoma.

Witt O, Deubzer HE, Lodrini M, Milde T, Oehme I. Witt O, et al. Curr Pharm Des. 2009;15(4):436-47. doi: 10.2174/138161209787315774. Curr Pharm Des. 2009. PMID: 19199971 Review.

7

Targeting of HDAC8 and investigational inhibitors in neuroblastoma.

Oehme I, Deubzer HE, Lodrini M, Milde T, Witt O. Oehme I, et al. Among authors: witt o. Expert Opin Investig Drugs. 2009 Nov;18(11):1605-17. doi: 10.1517/14728220903241658. Expert Opin Investig Drugs. 2009. PMID: 19780707 Review.

8

HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.

Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, Deubzer HE, Lodrini M, Taylor MD, von Deimling A, Pfister S, Witt O. Milde T, et al. Among authors: witt o. Clin Cancer Res. 2010 Jun 15;16(12):3240-52. doi: 10.1158/1078-0432.CCR-10-0395. Epub 2010 Apr 22. Clin Cancer Res. 2010. PMID: 20413433

9

Molecular staging of intracranial ependymoma in children and adults.

Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, Milde T, Bender S, Wittmann A, Schöttler A, Kulozik AE, Witt O, von Deimling A, Lichter P, Pfister S. Korshunov A, et al. Among authors: witt h, witt o. J Clin Oncol. 2010 Jul 1;28(19):3182-90. doi: 10.1200/JCO.2009.27.3359. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516456

10

Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.

Rieken S, Gaiser T, Mohr A, Welzel T, Witt O, Kulozik AE, Wick W, Debus J, Combs SE. Rieken S, et al. Among authors: witt o. BMC Cancer. 2010 Aug 23;10:450. doi: 10.1186/1471-2407-10-450. BMC Cancer. 2010. PMID: 20731859 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page